Publication details

Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanisms

Investor logo
Investor logo
Authors

MIKULOVÁ Antónia PLEŠINGEROVÁ Hana CHORVÁTOVÁ Michaela KEBKOVÁ Pavlína BARTOŠÍKOVÁ Jana PROCHÁZKOVÁ SCHRUMPFOVÁ Petra VERNER Jan MULIDRÁN Dominik ČADA Štěpán VONDÁLOVÁ BLANÁŘOVÁ Olga KOLČÁKOVÁ Nela LOJA Tomáš KURUCOVÁ Terézia HOFERKOVÁ Eva TICHÝ Boris KOTAŠKOVÁ Jana MRÁZ Marek KUBALA Lukáš JANOVSKÁ Pavlína BRYJA Vítězslav

Year of publication 2026
Type Article in Periodical
Magazine / Source HemaSphere
MU Faculty or unit

Faculty of Science

Citation
web https://onlinelibrary.wiley.com/doi/10.1002/hem3.70343
Doi https://doi.org/10.1002/hem3.70343
Keywords Chronic Lymphocytic Leukemia (CLL); Casein kinase 1 (CK1?/?); CK1 inhibitors; NF-?B; Tumor microenvironment; Eµ-TCL1 model; Cell cycle
Attached files
Description Chronic lymphocytic leukemia (CLL) is a consequence of pathological B-cell accumulation in blood and lymphoid organs. Due to high refractoriness, CLL is still incurable in many cases; therefore, there is an urgent need to develop novel therapeutic options. We have shown earlier that inhibition of casein kinase 1 delta/epsilon (CK1 delta/epsilon) is a promising CLL treatment strategy. Herein, we elucidate the molecular and cellular mechanisms mediating CK1 delta/epsilon inhibition efficacy in CLL. Using an in vivo E & micro;-TCL1 adoptive transfer model, we showed that CK1 delta/epsilon inhibition caused CLL cell accumulation at the S/G2 phase in a cell-intrinsic mode. Furthermore, CK1 delta/epsilon inhibition led to a T-cell decrease in lymph nodes (LNs). Using primary CLL cells and a system mimicking the LN microenvironment in vitro, we demonstrated that CK1 delta/epsilon inhibition interfered with multiple pro-survival mechanisms provided by the microenvironment, most notably with the nuclear factor kappa B (NF kappa B) pathway. NF kappa B acts downstream of the T-cell-mediated CD40L:CD40 stimulus, and indeed, CK1 delta/epsilon inhibition efficiently blocked the proliferation of primary CLL triggered by CD40L across multiple patient groups, with lower efficacy in patients with TP53 defects. We propose that CK1 delta/epsilon inhibitors act in the multiple-hit mode, striking both intrinsically via direct interference with cell cycle machinery and extrinsically via inhibition of multiple pro-proliferative stimuli.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info